See how this combination medicine may be right for you
Even if you’re eating right, staying active, and taking your injectable diabetes medicine every day, you may still be struggling to reach your A1C goal. Xultophy® 100/3.6 may be able to help you.
Xultophy® 100/3.6 is indicated to lower blood sugar along with diet and exercise in adults with type 2 diabetes uncontrolled on less than 50 units of long-acting insulin daily. A single daily dose of Xultophy® 100/3.6 showed similar A1C results to 1 long-acting and up to 4 mealtime insulin injections.
What makes Xultophy® 100/3.6 different?
Xultophy® 100/3.6 is different because it combines 2 proven diabetes medicines—Tresiba® (insulin degludec) and Victoza® (liraglutide)—in 1 pen. Since you are already taking an injectable diabetes medicine, switching to Xultophy® 100/3.6 allows you to add another medicine without adding another injection.
This once-daily combination medicine used with diet and exercise can help lower blood sugar for a full 24 hours, including after you eat.
Save on Xultophy® 100/3.6
With the Xultophy® 100/3.6 Savings Card, eligible patients pay as little as $1 per day. With your card, you’ll receive a free box of Novo Nordisk needles and a maximum monthly savings of $400 for up to 24 months. Eligibility and other restrictions apply.